Revolutionary Predictive AI
MyndBlue is a company that develops
revolutionary predictive AI based digital
therapeutic for early detection of
complications & relapse in MDD and PTSD.
Who are we, and what do we want to resolve?
We are a multisciplinary team of psychiatrists, clinical psychologists, pharmacists, mathematicians, & engineers whose passion is tackling tough challenges in the real world.
The deep understanding of patient & physician’s needs permits us to design a highly accurate prediction algorithm that is transparent, understandable, and trustworthy to support decisionmakers.
The result is a highly accurate prediction algorithm to support physicians under messy real-world data conditions.
If we had anticipated earlier...
Every day, doctors are faced with the fait accompli of suffering patients relapsing into depression and the transition to chronic PTSD.
Unfortunately, most of these patients continue to suffer because they have no foreknowledge of a coming MDD or PTSD relapse. By using predictive biomarkers built with predictive AI, we are capable of predicting risks in a patient’s disease-status earlier.
A signal is sent to their doctor immediately for intervention, before a relapse of MDD or PTSD occurs. The solution lies in radical new approach to capturing & predicting objective informations.
Digital Therapeutic to build precision & personalized medicine
Our shared vision is to be at the forefront of building precision
medicine in mental health by relying on predictive AI.
MDD & PTSD : High-stake in numbers
30% of patients suffering from MDD have full recovery(1)
25% of patients suffering from MDD lost to monitor(2)
64% of patient suffering from acute PTSD evolve to chronic PTSD(3)
80% of chronic PTSD develop depression, bipolar or substance abuse disorder(4)